Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Once the optimal dosage for promoting appetite control and weight loss has been established, the duration of treatment is determined, which varies according to the individuals response
These mimic the actions of the hormone GLP-1 (short for glucagon-like peptide-1 receptors), which regulates blood sugar levels by stimulating insulin release
Clinical testing showed a 23% increase in net elasticity and a 22% improvement in firmness after 12 weeks measurable results that translate to tighter, more supple skin
McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR
Published Phase 2 effect sizes most prominently the ~24 percent mean body weight reduction at the 12 mg dose tier in the obesity Phase 2 (PMID 37366315) exceed those reported for dual or single agonists at comparable durations, an outcome that researchers attribute to the additional glucagon-arm contribution to body-composition and energy-expenditure pathways
Research has shown that the glucagon component specifically targets visceral fat reduction and hepatic lipid metabolism, which are areas where single-agonist compounds show less activity
